Metabolism - Clinical and Experimental
Volume 44, Issue 7 , Pages 899-905 , July 1995

Effects of beta-blockade on hepatic conversion of amino acid nitrogen and on urea synthesis in cirrhosis

Received 2 May 1994 ,Accepted 23 November 1994.

References 

  1. Poynard T, Calès P, Pasta L, et al.  Beta-adrenergic-antagonist drugs in the prevention of gastrointestinal bleeding in patients with cirrhosis and esophageal varices. In: An analysis of data and prognostic factors in 589 patients from four randomized clinical trials. N Engl J Med. 324:1991;p. 1532–1538
  2. Bowman WC. Effects of adrenergic activators and inhibitors on the skeletal muscles. In:  Szekeres L editors. Handbook of Experimental Pharmacology. vol 54:Heidelberg, Germany: Springer-Verlag; 1980;p. 47–128
  3. Muscling in on clembuterol. Lancet. 1992;340:403; (editorial)
  4. Yang YT, McElligot MA. Multiple actions of β-adrenergic agonists on skeletal muscle and adipose tissue. Biochem J. 1989;261:1–10
  5. Shamoon H, Jacob R, Sherwin RS. Epinephrine-induced hypoaminoacidemia in normal and diabetic human subjects. In: Effect of beta blockade. Diabetes. 29:1980;p. 875–881
  6. Vilstrup H. On urea synthesis—Regulation in vivo. Dan Med Bull. 1989;36:415–429
  7. Rosen HM, Yoshimura N, Hodgman JM, et al.  Plasma amino acids patterns in hepatic encephalopathy of differing etiology. Gastroenterology. 1977;72:483–487
  8. Eriksson LS, Söderman C. Influence of beta blockade on branched chain amino acid concentration in cirrhosis. Hepatogastroenterology. 1992;39:451–454
  9. Pugh RNH, Murray-Lyon IM, Dawson JL, et al.  Transection of the oesophagus for bleeding oesophageal varices. Br J Surg. 1973;60:646–649
  10. Bianchi GP, Marchesini G, Vilstrup H, et al.  Hepatic amino-nitrogen conversion to urea-nitrogen in control subjects and in patients with cirrhosis: A simplified method. Hepatology. 1991;13:460–466
  11. Soberman R, Brodie BB, Levy BB, et al.  The use of antipyrine in the measurement of total body water in man. J Biol Chem. 1949;179:31–42
  12. Hansen BA, Vilstrup H. Increased intestinal hydrolysis of urea in patients with alcoholic cirrhosis. Scand J Gastroenterol. 1985;20:346–350
  13. Vilstrup H, Hansen BA, Almdal TP. Glucagon increases hepatic efficacy for urea synthesis. J Hepatol. 1990;10:46–50
  14. Zoli M, Marchesini G, Brunori A, et al.  Portal venous flow in response to acute b-blocker and vasodilatatory treatment in patients with liver cirrhosis. Hepatology. 1986;6:1248–1251
  15. Tygstrup N. Determination of the hepatic elimination capacity (Lm) of galactose by single injection. Scand J Clin Lab Invest. 1966;18:118–125
  16. Fabbri A, Bianchi GP, Marchesini G, et al.  Total body water and one-sample antipyrine clearance in advanced liver cirrhosis. In:  Gentilini P,  Dianzani MU editor. Experimental and Clinical Hepatology. Amsterdam, The Netherlands: Excerpta Medica; 1991;p. 219–225
  17. Marchesini G, Bua V, Brunori A, et al.  Galactose elimination capacity and liver volume in aging man. Hepatology. 1988;8:1079–1083
  18. Fawcett JK, Scott JE. A rapid and precise method for determination of urea. J Clin Pathol. 1960;13:156–159
  19. Williamson DH. l-Alanine. In: Determination with alanine dehydrogenase.  Bergmeyer HU editors. Methods in Enzymatic Analysis. New York, NY: Academic; 1974;p. 1679–1681
  20. Goodwin JF. Spectrophotometric quantitation of plasma and urinary amino nitrogen with fluorodinitrobenzene. Stand Meth Clin Chem. 1970;6:89–98
  21. Marchesini G, Bianchi GP, Vilstrup H, et al.  Plasma clearances of branched-chain amino acids in control subjects and in patients with cirrhosis. J Hepatol. 1987;4:108–117
  22. Grossi G, Bargossi AM, Lucarelli L, et al.  Improvements in automated analysis of catecholamines and related metabolites in biological samples by column switching high-performance liquid chromatography. J Chromatogr. 1991;541:273–284
  23. Fabbri A, Bianchi G, Zoli M, et al.  Effect of physical exercise on one-sample antipyrine clearance. Ital J Gastroenterol. 1991;23:74–76
  24. Weber FL, Banwell JG, Fresard KM, et al.  Nitrogen in fecal bacterial, fibers and soluble fractions of patients with cirrhosis: Effect of lactulose plus neomycin. J Lab Clin Med. 1987;110:259–263
  25. Keiding S. Hepatic clearance and liver blood flow. J Hepatol. 1987;4:393–398
  26. Morris SM, Monkman CL, O'Brien WE. Modulation of mRNA levels for urea cycle enzymes in rat liver by diet and hormones. Ann NY Acad Sci. 1986;478:292–294
  27. Petersen KF, Vilstrup H, Tygstrup N. Effect of dietary protein on the capacity of urea synthesis in rats. Horm Metab Res. 1990;22:612–615
  28. Hamberg O, Nielsen K, Vilstrup H. Effects of an increase in protein intake on hepatic efficacy for urea synthesis in healthy subjects and in patients with cirrhosis. J Hepatol. 1992;14:237–243
  29. Snodgrass PJ, Lin RC, Mueller WA, et al.  Induction of urea cycle enzymes of rat liver by glucagon. J Biol Chem. 1978;253:2748–2753
  30. Almdal TP, Vilstrup H. Loss of nitrogen from organs in rats induced by exogenous glucagon. Endocrinology. 1988;123:2182–2186
  31. Fabbri A, Marchesini G, Bianchi GP, et al.  Unresponsiveness of hepatic nitrogen metabolism to glucagon infusion in patients with cirrhosis: Dependence on liver cell failure. Hepatology. 1993;18:28–35
  32. Heindorff H, Vilstrup H, Almdal T, et al.  Elective cholecystectomy increases plasma amino-acid clearance and hepatic capacity for urea synthesis for one week. Clin Nutr. 1991;10:10–17
  33. Simmons PS, Miles JM, Gerich JE, et al.  Increased proteolysis. In: An effect of increases in plasma cortisol within the physiologic range. J Clin Invest. 73:1984;p. 412–420
  34. Marco J, Calle C, Romain D, et al.  Hyperglucagonemia induced by glucocorticoids treatment in man. N Engl J Med. 1973;288:128–131
  35. Heindorff H, Almdal T, Vilstrup H. Effects of epinephrine on urea synthesis in rats. Liver. 1992;12:46–49
  36. Heindorff H, Schulze S, Mogensen T, et al.  Hormonal and neural blockade prevents the postoperative increase in amino acid clearance and urea synthesis. Surgery. 1992;111:543–550
  37. Cerasi E, Luft R, Efendic S. Effect of adrenergic blocking agents on insulin response to glucose infusion in man. Acta Endocrinol (Copenh). 1972;69:335–342
  38. Hamberg O, Vilstrup H. Effects of insulin on urea synthesis in man. Ital J Gastroenterol. 1992;24(suppl 1):6; abstr
  39. Berger M, Zimmerman-Telschow H, Berchtold P, et al.  Blood amino acid levels in patients with insulin excess (functioning insulinoma) and insulin deficiency (diabetic ketosis). Metabolism. 1978;27:793–799
  40. Bosch J, Masti R, Kravetz D, et al.  Effects of propranolol on azygos venous blood flow and hepatic and systemic hemodynamics in cirrhosis. Hepatology. 1984;4:1200–1205
  41. Zeman RJ, Ludermann R, Easton TG, et al.  Slow to fast alterations in skeletal muscle fibers caused by clenbuterol, a β2-receptor agonist. Am J Physiol. 1988;254:E726–E732
  42. Rizack MA. An epinephrine-sensitive lipolytic activity in adipose tissue. J Biol Chem. 1961;236:657–662
  43. Lamont LS, Patel DG, Kalhan SC. B-Adrenergic blockade alters whole-body leucine metabolism in humans. J Appl Physiol. 1989;67:221–225
  44. Reeds PJ, Hay SM, Dorwood PM, et al.  Stimulation of muscle growth by clenbuterol: Lack of effect on muscle protein biosynthesis. Br J Nutr. 1986;56:249–258
  45. Marchesini G, Fabbri A, Bianchi GP, et al.  Hepatic conversion of amino nitrogen into urea in thyroid diseases. II. A study in hyperthyroid patients. Metabolism. 1994;44:1023–1029

☆ Supported by a grant from the Ministero dell'Università e della Ricerca Scientifica, Rome, Italy (Fondi 60%, 1994).

PII: 0026-0495(95)90243-0

Metabolism - Clinical and Experimental
Volume 44, Issue 7 , Pages 899-905 , July 1995

Article Tools